Anna Nasierowska‐Guttmejer

Author

The Maria Sklodowska-Curie National Research Institute of Oncology ORCID

Also Known As

A Nasierowska-Guttmejer, A. M. Nasierowska-Guttmejer, A. Nasierowska-Guttmejer, A. Nasierowska‐Guttmejer, Anna Guttmejer-Nasierowska, Anna M Nasierowska-Guttmejer, Anna M. Nasierowska-Guttmejer, Anna Maria Nasierowska-Guttmejer, Anna Nasierowska-Guttmejer, Anna Nasierowska‐Guttmejer

216

Publications

Citations

H-Index

Concepts

All Affiliations

The Maria Sklodowska-Curie National Research Institute of Oncology Central Clinical Hospital Medical University of Warsaw Jan Kochanowski University Gdańsk Medical University

About

Anna Nasierowska‐Guttmejer is an author at The Maria Sklodowska-Curie National Research Institute of Oncology specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	1.6K
2	Health Sciences	8	8	911
3	Public Health	2	2	26
4	Cell Biology	2	2	31
5	Biostatistics	1	1	15

Anna Nasierowska‐Guttmejer

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer Krzysztof Bujko, Marek P. Nowacki, Anna Nasierowska‐Guttmejer, British journal of surgery	2006	1.2K
Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy Krzysztof Bujko, Marek P. Nowacki, Anna Nasierowska‐Guttmejer, Radiotherapy and Oncology Surgical OncologyRadiation TherapyColorectal SurgeryRandomised TrialMedicine	2004	502
Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate Piotr Rutkowski, Zbigniew Nowecki, Paweł Nyckowski, Journal of Surgical Oncology	2006	186
Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study A Sankowski, Nina Seklecka, John Buscombe, Annals of Oncology MedicineRadionuclide TherapyPhase Ii StudyRadiopharmaceutical TherapyCancer Treatment	2009	170
Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour – The impact of tumour rupture on patient outcomes Piotr Rutkowski, Elżbieta Bylina, Agnieszka Woźniak, European Journal of Surgical Oncology Surgical OncologyTumour RuptureGastrointestinal OncologyMedicineJoensuu Risk Criteria	2011	168
Diagnostic yield and safety of endoscopic-ultrasound guided trucut biopsy in patients with gastric submucosal tumors: a prospective study Marcin Polkowski, W Gerke, D. Jarosz, Endoscopy	2009	128
Argon Plasma Coagulation after Piecemeal Polypectomy of Sessile Colorectal Adenomas: Long-Term Follow-Up Study Ewa Wrońska, Marcin Polkowski, Anna Nasierowska‐Guttmejer, Endoscopy	2003	123
Risk of stomach cancer in relation to consumption of cigarettes, alcohol, tea and coffee in Warsaw, Poland Wong‐Ho Chow, Christine A. Swanson, Jolanta Lissowska, International Journal of Cancer	1999	121
Endosonography Versus Helical Computed Tomography for Locoregional Staging of Gastric Cancer Marcin Polkowski, Ewa Wrońska, Anna Nasierowska‐Guttmejer, Endoscopy	2004	111
Survival Analysis and Clinicopathological Factors Associated With False-Negative Sentinel Lymph Node Biopsy Findings in Patients with Cutaneous Melanoma Zbigniew Nowecki, Piotr Rutkowski, Anna Nasierowska‐Guttmejer, Annals of Surgical Oncology Dermoscopic ImageMedicineSurgical PathologyMelanomaPathology	2006	99

Page 1